Skip to main content

Table 1 The distribution of various gingival lesions based on the patients’ age and gender

From: Clinicopathological study of 1000 biopsied gingival lesions among dental outpatients: a 22-year retrospective study

Lesion

Frequency

N (%)

Age (Mean ± SD)

M:F

Irritation fibroma

85 (8.5)

35.62 ± 15.34

32:53

POF

167 (16.7)

31.30 ± 15.66

66:101

IFH

51 (5.1)

58.88 ± 13.06

15:36

Pyogenic granuloma

246 (24.6)

35.50 ± 17.01

81:165

PGCG

150 (15.0)

38.36 ± 20.64

75:74

Epulis granulomatosa

7 (0.7)

47.16 ± 29.43

3:4

Giant cell fibroma

12 (1.2)

34.09 ± 23.91

8:4

Neurofibroma

19 (1.9)

40.11 ± 18.99

7:12

Hemangioma

3 (0.3)

27.00 ± 22.51

2:1

Malignant mesenchymal tumor

7 (0.7)

43.42 ± 18.20

3:4

Oral melanotic macule

13 (1.3)

39.41 ± 9.36

3:10

Hyperkeratosis

22 (2.2)

46.95 ± 16.96

10:12

Epithelial dysplasia

5 (0.5)

53.80 ± 7.25

2:3

Squamous papilloma

4 (0.4)

37.75 ± 8.46

2:2

SCC

26 (2.6)

59.7 ± 14.08

14:12

Melanoma

2 (0.2)

55 ± 0.00

1:1

Undifferentiated carcinoma

2 (0.2)

55.50 ± 13.43

2:0

Lichenoid reaction

43 (4.3)

48.04 ± 11.76

1:42

Pemphigoid

6 (0.6)

49.83 ± 13.49

0:6

Lichen planus

34 (3.4)

43.03 ± 12.18

7:27

Pemphigus

6 (0.6)

37.66 ± 10.63

0:6

Plasma cell gingivitis

4 (0.4)

32.75 ± 21.46

0:4

Periodontitis/ Gingivitis

5 (0.5)

27.60 ± 6.42

0:5

Peripheral odon. fibroma

3 (0.3)

22.00 ± 8.71

0:3

Lymphoma

3 (0.3)

55.33 ± 30.17

1:2

Exogenous pigmentation

5 (0.5)

32.00 ± 14.66

1:4

Non-specific lesions

57 (5.7)

39.63 ± 17.24

22:35

Others

13 (1.3)

27.34 ± 18.49

0:13

Total

1000 (100)

38.72 ± 18.30

359:640

  1. POF peripheral ossifying fibroma, IFH inflammatory fibrous hyperplasia, PGCG peripheral giant cell granuloma, SCC squamous cell carcinoma, Odon odontogenic